Usefulness of the uric acid and CHA2DS2-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm

Cardiology Journal

Volumn 22, Issue 3, 2015, Pages 336-342

  Ozturk, Derya ^a   Celık, Omer ^a   Akın, Fatıh ^b   Akturk, Faruk ^a   Aslan, Serkan ^a   Ozyılmaz, Sınem Ozbay ^a   Bırand, Alı ^a   Yıldırım, Aydın ^a  

^a ISTANBUL MEHMET AKIF ERSOY THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

Author keywords

CHA2DS2 VASc score; Left atrial thrombosis; Mitral stenosis; Sinus rhythm; Uric acid

Indexed keywords

C REACTIVE PROTEIN; URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHA2DS2 VASC SCORE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY SCORE; FEMALE; HEART ATRIUM THROMBOSIS; HEART SIZE; HUMAN; HYPERTENSION; LA ANTEROPOSTERIOR DIAMETER; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PREDICTION; SINUS RHYTHM; THROMBOCYTE VOLUME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; URIC ACID BLOOD LEVEL; BLOOD; COMPLICATION; DECISION SUPPORT SYSTEM; ECHOGRAPHY; HEART ATRIUM; HEART DISEASES; HYPERURICEMIA; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; UPREGULATION;

ADULT; BIOMARKERS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; UP-REGULATION; URIC ACID;

EID: 84931308325     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2014.0059     Document Type: Article

References (42)

1. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL.Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. J Am Coll Cardiol, 2000; 35: 183-187.
2. Ozkan M, Kaymaz C, Kirma C et al. Predictors of left atrial thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement. Am J Cardiol, 1998; 82: 1066-1070.
3. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH. Predictors of systemic embolism in patients with mitral stenosis: A prospective study. Ann Intern Med, 1998; 128: 885-889.
4. Vigna C, Russo A, DeRito V et al. Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and ischemic dilated cardiomyopathy. Am J Cardiol, 1992; 70: 1500-1501.
5. Ammash NM, Seward JB, Bailey KR, Edwards WD, Tajik AJ. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation, 2000; 101: 2490-2496.
6. Davison G, Greenland P. Predictors of left atrial thrombus in mitral valve disease. J Gen Intern Med, 1991; 6: 108-112.
7. Conradie C, Schall R, Marx JD. Echocardiographic study of left atrial thrombi in mitral stenosis. Clin Cardiol, 1993; 16: 729-731.
8. Saidi SJ, Motamedi MHK. Incidence and factors influencing left atrial clot in patients with mitral stenosis and normal sinus rhythm. Heart, 2004; 90: 1342-1343.
9. Kasliwal RR, Mittal S, Kanojia A et al. A study of spontaneous echo contrast in patients with rheumatic mitral stenosis and normal sinus rhythm: An Indian perspective. Br Heart J, 1995;74: 296-299.
10. Agmon Y, Khandheria BK, Gentile F, Seward JB. Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol, 1999; 34: 1867-1877.
11. Apek M, Kaya MG, Yarlioglues M et al. Relationship between platelet indices and spontaneous echo contrast in patients with mitral stenosis. Eur J Echocardiogr, 2011; 2012: 865-870.
12. Roldán V, Marıín F, Blann AD et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J, 2003; 24: 1373-1380.
13. Conway DS, Buggins P, Hughes E, Lip GY. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol, 2004; 43: 2075-2082.
14. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: A systemic review and meta-analysis. Arthritis Care Res, 2011; 14: 102-110.
15. Nashar K, Fried LF. Hyperuricemia and the progression of chronic kidney disease: Is uric acid a marker or an independent risk factor. Adv Chronic Kidney Dis, 2012; 14: 386-391.
16. Tamariz L, Verma S. Uric acid as a predictor of all-cause mortality in heart failure: A Meta-analysis. Congest Heart Fail, 2011; 14: 25-30.
17. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander? Metabolism, 2006; 14: 1293-301.
18. Kodama S, Saito K, Yachi Y et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care, 2009; 14: 1737-1742
19. Fang J, Alderman M. Serum uric acid and cardiovascular mortality. JAMA, 2000; 283: 2404-2410.
20. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417734 men and women in the Apolipoprotein Mortality RISK study (AMORIS). J Intern Med, 2009; 266: 558-570.
21. Strasak AM, Kelleher CC, Brant LJ et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol, 2008; 125: 232-239.
22. Storhaug HM, Norvik JV, Toft I et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: A gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord, 2013; 13: 115.
23. Li M, Hou W, Zhang X, Hu L, Tang Z. Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies. Atherosclerosis, 2014; 232: 265-270.
24. Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM. Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm, 2014; 11: 1102--1108.
25. Chao TF, Liu CJ, Chen SJ et al. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation: Could it refine clinical risk stratification in AF? Int J Cardiol, 2014; 170: 344-349.
26. Nyrnes A, Toft I, Njølstad I et al. Uric acid is associated with future atrial fibrillation: An 11-year follow-up of 6308 men and women: The Tromso Study. Europace, 2014; 16: 320-326.
27. Chao TF, Liu CJ, Chen SJ et al. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation--could it refine clinical risk stratification in AF? Int J Cardiol, 2014; 170: 344-349.
28. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol, 2005; 14: 39-42.
29. Rothenbacher D, Kleiner A, Koenig W, Primatesta P, Breitling LP, Brenner H. Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease. PLoS One, 2012; 7: e45907.
30. Ruggiero C, Cherubini A, Ble A et al. Uric acid and inflammatory markers. Eur Heart J, 2006; 27: 1174-1181.
31. Lang RM, Bierig M, Devereux RB et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr, 2006; 7: 79-108.
32. Agmon Y, Khandheria BK, Gentile F, Seward JB. Clinical and echocardiographic characteristics of patients with left atrial thrombus and sinus rhythm: Experience in 20 643 consecutive transesophageal echocardiographic examinations. Circulation, 2002; 105: 27-31.
33. Srimannarayana J, Varma RS, Satheesh S, Anilkumar R, Balachander J. Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: A transesophageal echocardiographic study. Indian Heart J, 2003; 55: 358-361.
34. Manjunath CN, Srinivasa KH, Panneerselvam A et al. Incidence and predictors of left atrial thrombus in patients with rheumatic mitral stenosis and sinus rhythm: A transesophageal echocardiographic study. Echocardiography, 2011; 28: 457-460.
35. Li YH, Hwang JJ, Ko YL et al. Left atrial spontaneous echo contrast in patients with rheumatic mitral valve disease in sinus rhythm: Implication of an altered left atrial ap- pendage function in its formation. Chest, 1995; 108: 99-103.
36. Agarwal AK, Venugopalan P. Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: Relationship to mitral valve and atrial measurements. Int J Cardiol, 2001; 77: 63-68
37. Atak R, Yetkin E, Yetkin O et al. Increased systemic and regional coagulation activity in patients with mitral stenosis and sinus rhythm. Angiology, 2003; 54: 593-597.
38. Karthikeyan G, Thachil A, Sharma S, Kalaivani M, Ramakrishnan L. Elevated high sensitivity CRP levels in patients with mitral stenosis and left atrial thrombus. Int J Cardiol, 2007; 122: 252-254.
39. Kaya MG, Akpek M, Elcik D et al. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Am J Cardiol, 2012; 109: 851-855.
40. Mustard JF, Murphy EA, Ogryzlo MA, Smythe HA. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J, 1963; 89: 1207-1211.
41. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol, 2005; 16: 3553-3562.
42. Chao TF, Hung CL, Chen SJ et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol, 2013; 168: 4027-4032.